Approving J&J's new depression drug would be an unusual move for the FDA - BioPharma Dive

Submitted by Anonymous (not verified) on Fri, 02/08/2019 - 17:34

Approving J&J's new depression drug would be an unusual move for the FDA  BioPharma DiveThe Food and Drug Administration would be making an unusual move if it greenlights Johnson & Johnson's experimental depression treatment, according to a ...